June 29, 2022 / by Health Plan / Uncategorized
Code Description PA Coverage Criteria J9144 INJECTION, DARATUMUMAB, 10MG AND HYALURONIDASE-FIHJ Approval is determined by medical necessity criteria Q5108 INJECTION, PEGFILGRASTIMJMDB, BIOSIMILAR, (FULPHILA), 0.5 MG Q5110 INJECTION, FILGRASTIM-AAFI, BIOSIMILAR, (NIVESTYM), 1 MCG Q5111 INJECTION, PEGFILGRASTIMCBQV, BIOSIMILAR, (UDENYCA), 0.5 MG Q5101 INJECTION, FILGRASTIM-SNDZ, BIOSIMILAR, (ZARXIO), 1 MCG J1447 INJECTION, […]
Read more
well visit page
July 11, 2022 / by Health Plan / Uncategorized
Read more
REMINDER- Authorization Required on Claims
July 6, 2022 / by Health Plan / Alerts
Date: July 5, 2022 To: Health Plan of San Joaquin (HPSJ) All Providers & Facilities From: HPSJ Subject: REMINDER- Authorization Required on Claims Business: Medi-Cal Managed Care An internal claims audit revealed that the prior authorization number (entered on a CMS 1500 claim form) and the treatment authorization number (entered on a UB04 claim form) [...]Read more
Proposition 56 Value-Based Payment Programing Has Ended
July 6, 2022 / by Health Plan / Alerts
Date: July 5, 2022 To: HPSJ Primary Care Providers (PCP) and Contracted Facilities From: Health Plan of San Joaquin (HPSJ) Subject: Proposition 56 Value-Based Payment Programing Has Ended Business: Medi-Cal Managed Care The Value-Based Payment (VBP) Program has ended effective June 30, 2022. The VBP Program was directed to Managed Care Plans (MCPs) to make [...]Read more
Revised DHCS Facility Site Review and Medical Record Review Tools and Standards
July 1, 2022 / by Health Plan / Alerts
Date: July 1, 2022 To: Health Plan of San Joaquin (HPSJ) PCP’s and FQHCs From: HPSJ Quality Management Department Type: Informational/Regulatory Subject: Revised DHCS Facility Site Review and Medical Record Review Tools and Standards Business: Medi-Cal Managed Care Beginning July 1, 2022, the Department of Health Care Services (DHCS) will be implementing the use of [...]Read more
2022 Mandatory Annual Trainings Final Reminder
July 1, 2022 / by Health Plan / Alerts
Date: June 30, 2022 To: Health Plan of San Joaquin (HPSJ) Practitioners, Providers & Facilities From: Health Plan of San Joaquin Subject: 2022 Mandatory Annual Trainings Final Reminder Business: Medi-Cal ACTION REQUIRED Please complete ALL THREE trainings by June 30, 2022 Annual training is mandated by California’s Department of Health Care Services (DHCS) and the [...]Read more
Medical Benefit Updates
June 30, 2022 / by Health Plan / Alerts
Date: June 30, 2022 To: Health Plan of San Joaquin (HPSJ) Physicians and Providers From: Health Plan of San Joaquin Pharmacy and Therapeutics Committee Subject: Medical Benefit Updates Business: Medi-Cal Managed Care Effective September 5, 2022, the Pharmacy and Therapeutics Committee has approved the following changes to the medical benefit: Code J2357 - INJECTION, OMALIZUMAB [...]Read more
Reminder: Phase 2: ECM and Community Supports – San Joaquin and Stanislaus Counties
June 30, 2022 / by Health Plan / Alerts
Date: June 30, 2022 To: HPSJ Primary Care Providers, Specialists, Hospitals and Facilities From: Health Plan of San Joaquin Subject: Reminder: Phase 2: ECM and Community Supports – San Joaquin and Stanislaus Counties Business: Medi-Cal Enhanced Care Management and Community Supports Starting in January of 2022, new benefits and services called Enhanced Care Management (ECM) [...]Read more
2022 Mandatory Annual Training – Reminder Table
June 29, 2022 / by Health Plan / Alerts
Date: June 17, 2022 To: Health Plan of San Joaquin Practitioners, Contracted Providers, Facilities, and Behavioral Health Providers From: Health Plan of San Joaquin Subject: 2022 Mandatory Annual Training – Reminder Table Business: Medi-Cal Type of Training Requirement Due Date Health Insurance Portability and Accountability Act (HIPAA) HIPAA is a federal law that required […]
Read more
Medical Benefit Updates Table
June 29, 2022 / by Health Plan / Uncategorized
Code Description PA Coverage Criteria J9144 INJECTION, DARATUMUMAB, 10MG AND HYALURONIDASE-FIHJ Approval is determined by medical necessity criteria Q5108 INJECTION, PEGFILGRASTIMJMDB, BIOSIMILAR, (FULPHILA), 0.5 MG Q5110 INJECTION, FILGRASTIM-AAFI, BIOSIMILAR, (NIVESTYM), 1 MCG Q5111 INJECTION, PEGFILGRASTIMCBQV, BIOSIMILAR, (UDENYCA), 0.5 MG Q5101 INJECTION, FILGRASTIM-SNDZ, BIOSIMILAR, (ZARXIO), 1 MCG J1447 INJECTION, […]
Read more
Protected: Sutter Contract Termination 2022 Table
June 29, 2022 / by Health Plan / Uncategorized
There is no excerpt because this is a protected post.
Read more